Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Press center
  3. Press features
  4. Capital Markets Day 2025
Press Feature

Capital Markets Day 2025

Siemens Healthineers holds its Capital Markets Day on November 17.
The management team will present the next strategy phase, the financial framework and the mid-term financial outlook.
Published on November 17, 2025

Siemens Healthineers Announces New Strategy Phase “Elevating Health Globally”, Mid-term Targets

London, United Kingdom | Nov 17, 2025

  • Market and innovation leadership with healthcare AI as accelerator

  • Accelerating clinical impact through focusing on non-communicable diseases and driving customer impact to the next level

  • New “Precision Therapy” segment combines Varian, Advanced Therapies and Ultrasound

  • FY 2027-2030 annual revenue growth of 6-9% from synergetic core of Imaging and Precision Therapy

  • Double-digit group EPS growth and robust free cash flows

  • Diagnostics to pursue its own strategy in its own set-up

Virtual Events 

CMD slides

Pictures

Bernd Montag, CEO Siemens Healthineers, speaks at the company’s 2025 Capital Markets Day.

Bernd Montag, CEO Siemens Healthineers, speaks at the company’s 2025 Capital Markets Day. 
Download image

Management

Dr. Bernd Montag (Chief Executive Officer)

Bernd Montag
Chief Executive Officer, Siemens Healthineers
Press Pictures
Biography

Further Information